Shreyas Joshi, MD
@ssjoshi.bsky.social
Assistant Professor in Urologic Oncology, Emory University, Winship Cancer Institute
Reposted by Shreyas Joshi, MD
Join us for our SUO Fellowship Virtual Open House on January 13, 2026, 7-8 PM EST @ssjoshi.bsky.social @emoryuroonc.bsky.social . Register here: zoom.us/meeting/regi...
November 4, 2025 at 3:09 PM
Join us for our SUO Fellowship Virtual Open House on January 13, 2026, 7-8 PM EST @ssjoshi.bsky.social @emoryuroonc.bsky.social . Register here: zoom.us/meeting/regi...
Reposted by Shreyas Joshi, MD
My thanks to my #EmoryUrology family and the teams at #Apple and @hey.epic.com for helping us tell the @emoryhealthcareatl.bsky.social story of how clinician well-being is being prioritized through the use of great technology
www.apple.com/healthcare/s...
www.apple.com/healthcare/s...
Healthcare - Success Stories
Read the success stories of how health organizations around the world use Apple technology to reduce clinician burnout and deliver personalized care.
www.apple.com
May 23, 2025 at 2:56 AM
My thanks to my #EmoryUrology family and the teams at #Apple and @hey.epic.com for helping us tell the @emoryhealthcareatl.bsky.social story of how clinician well-being is being prioritized through the use of great technology
www.apple.com/healthcare/s...
www.apple.com/healthcare/s...
Reposted by Shreyas Joshi, MD
Congratulations to our very own @tgoodstein.bsky.social for being awarded the 2025 Society of Urologic Oncology #CGOncology #NMIBC Fellowship Grant at #AUA2025 @ssjoshi.bsky.social @drnarayan.com
April 30, 2025 at 4:15 AM
Congratulations to our very own @tgoodstein.bsky.social for being awarded the 2025 Society of Urologic Oncology #CGOncology #NMIBC Fellowship Grant at #AUA2025 @ssjoshi.bsky.social @drnarayan.com
Reposted by Shreyas Joshi, MD
Thanks again to Tommy Korn and everyone at Sharp Healthcare for hosting a fantastic Spatial Computing Health Care Summit - awesome to see all the amazing things people have been doing with Apple #VisionPro & to share some of what we’ve been able to do with our partners at #KarlStorz #SharpSpatial
February 1, 2025 at 8:50 PM
Thanks again to Tommy Korn and everyone at Sharp Healthcare for hosting a fantastic Spatial Computing Health Care Summit - awesome to see all the amazing things people have been doing with Apple #VisionPro & to share some of what we’ve been able to do with our partners at #KarlStorz #SharpSpatial
Reposted by Shreyas Joshi, MD
“Grateful to be at #SWIU surrounded by incredible women—friends, colleagues, and mentees. Inspired by the exchange of ideas and learning about topics that truly empower us to lead fulfilled and successful lives. Here’s to growth, community, and innovation! 🩷 #WomenInUrology” @emoryuroonc.bsky.social
January 25, 2025 at 7:12 PM
“Grateful to be at #SWIU surrounded by incredible women—friends, colleagues, and mentees. Inspired by the exchange of ideas and learning about topics that truly empower us to lead fulfilled and successful lives. Here’s to growth, community, and innovation! 🩷 #WomenInUrology” @emoryuroonc.bsky.social
Reposted by Shreyas Joshi, MD
Interested in learning about Emory’s
#SUO fellowship?
📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST
DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social
#SUO fellowship?
📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST
DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social
January 12, 2025 at 8:01 PM
Interested in learning about Emory’s
#SUO fellowship?
📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST
DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social
#SUO fellowship?
📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST
DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social
Reposted by Shreyas Joshi, MD
December 15, 2024 at 12:53 PM
Reposted by Shreyas Joshi, MD
Proud of our first @emoryuroonc.bsky.social SUO fellow #TaylorGoodstein making a splash in RCC research at the #SUO24 Winter Meeting
@ssjoshi.bsky.social @jackiebrownmd.bsky.social
@ssjoshi.bsky.social @jackiebrownmd.bsky.social
December 6, 2024 at 2:46 PM
Proud of our first @emoryuroonc.bsky.social SUO fellow #TaylorGoodstein making a splash in RCC research at the #SUO24 Winter Meeting
@ssjoshi.bsky.social @jackiebrownmd.bsky.social
@ssjoshi.bsky.social @jackiebrownmd.bsky.social
Packed house at SUO2024 for NMIBC discussion. Our thought leader @drnarayan.com from @emoryuroonc.bsky.social @winshipatemory.bsky.social
Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
December 5, 2024 at 5:41 PM
Packed house at SUO2024 for NMIBC discussion. Our thought leader @drnarayan.com from @emoryuroonc.bsky.social @winshipatemory.bsky.social
Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
Reposted by Shreyas Joshi, MD
Interesting study…only 56% OS at 5 years strikes me as lower than I would expect; by comparison an 80% 5 year OS was observed in the ph3 nado trial for BCG unresponsive pts (76% in CIS only patients, 86% in papillary dz). Worth calling out the 53% grade 3 AE rate as well… @emoryuroonc.bsky.social
☢️💊💉Trimodality therapy offers hope for recurrent T1 bladder cancer after BCG failure!
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
November 27, 2024 at 1:53 AM
Interesting study…only 56% OS at 5 years strikes me as lower than I would expect; by comparison an 80% 5 year OS was observed in the ph3 nado trial for BCG unresponsive pts (76% in CIS only patients, 86% in papillary dz). Worth calling out the 53% grade 3 AE rate as well… @emoryuroonc.bsky.social
Urology residents of @bsky.app , let us know if you will be in Dallas for SUO 2024 and would like to chat about the @emoryuroonc.bsky.social SUO Fellowship! @drnarayan.com @valentinagrajales.bsky.social
November 27, 2024 at 1:53 AM
Urology residents of @bsky.app , let us know if you will be in Dallas for SUO 2024 and would like to chat about the @emoryuroonc.bsky.social SUO Fellowship! @drnarayan.com @valentinagrajales.bsky.social
@emoryuroonc.bsky.social welcome to Bluesky!
November 25, 2024 at 1:45 AM
@emoryuroonc.bsky.social welcome to Bluesky!
Reposted by Shreyas Joshi, MD
Join the conversation on all things #bladdercancer #kidneycancer #prostatecancer and help grow the GU Oncology Starter Pack go.bsky.app/6NdMXmY
November 22, 2024 at 9:50 PM
Join the conversation on all things #bladdercancer #kidneycancer #prostatecancer and help grow the GU Oncology Starter Pack go.bsky.app/6NdMXmY
Reposted by Shreyas Joshi, MD
The non-coding RNA based classifier identifies urothelial carcinomas harboring less aggressive tumor biology associated with favorable outcomes after radical cystectomy
doi.org/10.1111/bju....
doi.org/10.1111/bju....
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy
Objective To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non-coding RNA (lncRNA)-based genomic profiling has suggested utility in i...
doi.org
November 19, 2024 at 10:32 AM
The non-coding RNA based classifier identifies urothelial carcinomas harboring less aggressive tumor biology associated with favorable outcomes after radical cystectomy
doi.org/10.1111/bju....
doi.org/10.1111/bju....